Astellas says its gene therapy study, halted when four children with a rare diso...
The FDA granted marketing approval to a home test for chlamydia and gonorrhea on...
Panels in both the House and Senate have now passed restrictions to drug middlem...
The patents on medicines and devices approved by the FDA were more frequently in...
The FDA is in the final stages of cementing sweeping changes to the Office of Re...
House lawmakers approved an amendment that, if it advances, would ban controvers...
A new study showed that lifestyle programs — in the real world — can help people...
Want to stay on top of the science and politics driving biotech today? Sign up t...
The German drug regulator is considering an export ban on Novo Nordisk's diabete...
The Food and Drug Administration’s top cancer drug regulator doesn’t always ask ...
As health care workers face higher risk of violence, hospitals are turning to sy...
The seismic shift in researchers from academic to biotech labs is already having...
Hospital systems have to decide: Do they want to be Apple or Android?
The true costs of mediocre insurance plans for medical students.
A class action lawsuit was filed against UnitedHealth and a subsidiary alleging ...
Advocates say that programs that treat food as medicine could go a long way towa...
